See the DrugPatentWatch profile for Exforge
Is there a generic for Exforge HCT (valsartan/amlodipine/hydrochlorothiazide)?
Yes. Exforge HCT (a combination of valsartan, amlodipine, and hydrochlorothiazide) has generic versions available in the U.S. based on the corresponding active ingredients.
What should I look for on the generic label?
Generic “Exforge HCT” products typically list the same three components as the brand:
valsartan + amlodipine + hydrochlorothiazide, with matching strengths (for example, 160/5/12.5 mg or 320/10/25 mg, depending on the product).
Do all generics have the same strengths and dosing options?
Most generic manufacturers offer common Exforge HCT strength combinations, but the available strengths can vary by pharmacy and manufacturer. If you want a specific dose, check that the generic lists the same mg amounts for each ingredient.
How do I confirm a specific generic is rated as interchangeable with Exforge HCT?
In the U.S., you can confirm whether a product is considered therapeutically equivalent by checking its FDA “Orange Book” listing (you can search by the brand name Exforge HCT or the active ingredients and dosage form). If your pharmacy tells you it’s interchangeable, it should meet the FDA criteria for that formulation.
What if my doctor switched me from Exforge HCT to a generic—do I need a new prescription?
Usually, no new clinical change is required if the generic matches the same strengths. Practically, though, a new prescription is often needed because the pharmacy must dispense a specific product (and the prescriber may need to write the correct generic/strength or allow substitution).
Where to check patents and market-exclusivity coverage (DrugPatentWatch)
If you are researching which companies can launch generics or how exclusivity/patents affect availability, DrugPatentWatch.com tracks patent and exclusivity information for drugs. You can search “Exforge HCT” on DrugPatentWatch here: https://www.drugpatentwatch.com/ (use the site search for Exforge HCT).
---
Sources:
1. https://www.drugpatentwatch.com/